In only a few years, GLP-1 medications have transformed obesity care for young people, lead author Sarah Messiah, professor of epidemiology and associate dean for research in the Peter ODonnell Jr
Treatment options include beta-blockers, antiarrhythmic drugs, catheter ablation, and implantable cardioverter defibrillators (ICDs), with ICDs being the most effective safeguard against arrhythmic sudden death [67]
Hepatic stellate cells support hematopoiesis and are liver-resident mesenchymal stem cells
The World Anti-Doping Agency bans BPC-157 in competitive sports
Combined metformin and exenatide versus only metformin treatments in polycystic ovary syndrome with abdominal obesity and network pharmacology of gene expression: evidence from a randomized clinical trial
Medicare enrollees will pay a $50 monthly copay to get the medications, according to Lilly and Nordisk officials